All In MedTech

FDA Clearance Tracker · P010055-S009

PROSTALUND CORETHERM SYSTEM AND PROSTALAND CORETHERM ACCESSORIES

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 30, 2014 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 30, 2014

Approved

Time to decision

159 days

Received Feb 21, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P010055-S009
Device name
PROSTALUND CORETHERM SYSTEM AND PROSTALAND CORETHERM ACCESSORIES
Applicant
Prostalund AB
Applicant location
Se-223 63 Lund
Received
Feb 21, 2014
Decided
Jul 30, 2014
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P010055

Device type

Device class
Class III

Every decision under product code MEQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT ORIFICE MEDICAL AB IN YSTAD, SWEDEN.

Source documents

Other decisions for Prostalund AB

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.